|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.475 USD | +3.15% |
|
+5.14% | +0.14% |
| Mar. 13 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
| Mar. 13 | Spero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from Russell 3000 Growth Index
| 1st Jan change | Capi. | |
|---|---|---|
| +0.14% | 77.07M | |
| -1.81% | 103B | |
| +0.52% | 95.71B | |
| +1.69% | 22.02B | |
| -17.52% | 20.9B | |
| -9.30% | 17.85B | |
| -41.01% | 16.21B | |
| -14.91% | 15.52B | |
| +3.76% | 13.86B | |
| +35.72% | 12.04B |
SPERO THERAPEUTICS, INC. 
